Report overview
Prostate cancer is the development of cancer in the prostate, a gland in the male reproductive system. This cancer develops slowly, with no early detectable symptoms for many years. The precise cause of prostate cancer is unknown; however, factors such as obesity, high calcium diet, lack of exercise, ethnicity (African American men), and old age contribute to its occurrence.
This report aims to provide a comprehensive presentation of the global market for Prostate Cancer Medicine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prostate Cancer Medicine. This report contains market size and forecasts of Prostate Cancer Medicine in global, including the following market information:
Global Prostate Cancer Medicine Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Prostate Cancer Medicine market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
LHRH Antagonists Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Prostate Cancer Medicine include AstraZeneca plc, Active Biotech, Bristol Myers-Squibb, Teva Pharmaceuticals Industries Ltd., Johnson & Johnson, Pfizer Inc., Bayer AG, Abbott Laboratories and Astellas Pharma Inc., etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Prostate Cancer Medicine companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Prostate Cancer Medicine Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Prostate Cancer Medicine Market Segment Percentages, by Type, 2022 (%)
LHRH Antagonists
LHRH Analogs
Antiandrogens
Pipeline Drugs for Hormonal Therapy
Global Prostate Cancer Medicine Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Prostate Cancer Medicine Market Segment Percentages, by Application, 2022 (%)
Age Below 55
Age 55-75
Age Above 75
Global Prostate Cancer Medicine Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Prostate Cancer Medicine Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Prostate Cancer Medicine revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Prostate Cancer Medicine revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
AstraZeneca plc
Active Biotech
Bristol Myers-Squibb
Teva Pharmaceuticals Industries Ltd.
Johnson & Johnson
Pfizer Inc.
Bayer AG
Abbott Laboratories
Astellas Pharma Inc.
Roche Holding AG
Outline of Major Chapters:
Chapter 1: Introduces the definition of Prostate Cancer Medicine, market overview.
Chapter 2: Global Prostate Cancer Medicine market size in revenue.
Chapter 3: Detailed analysis of Prostate Cancer Medicine company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Prostate Cancer Medicine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
